Cite

HARVARD Citation

    Won, S. et al. (2020). Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. Oncoimmunology. p. . [Online]. 
  
Back to record